Old Web
English
Sign In
Acemap
>
Paper
>
PO-1217: Safety of Nivolumab and stereotactic RT in metastatic renal carcinoma: early results of NIVES study
PO-1217: Safety of Nivolumab and stereotactic RT in metastatic renal carcinoma: early results of NIVES study
2020
Patrizia Ciammella
G. Timon
C. Masini
R.S. Belli
Francesco Salaroli
Renzo Mazzarotto
Alessio Bruni
C. Pinto
Cinzia Iotti
Keywords:
Metastatic renal carcinoma
Internal medicine
Oncology
early results
Medicine
Nivolumab
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]